Back to today’s briefing

Story perspectives

GLP-1 Use Soars: 35% of U.S. Households by 2030

11/26/2025

43 7

Summary

Story summary

GLP-1 weight-loss use is rising, with 23% of U.S. households using them.
Experts project 35% of households will use GLP-1s by 2030.
A JAMA Internal Medicine study found tirzepatide cessation leads to weight regain and worse cardiovascular health.
Circana reports GLP-1 users shift food purchases toward healthier options and higher health-benefit products.
Companies are adapting, and many former users may return to the medications.

1 of 1

Story summary

GLP-1 weight-loss use is rising, with 23% of U.S. households using them.
Experts project 35% of households will use GLP-1s by 2030.
A JAMA Internal Medicine study found tirzepatide cessation leads to weight regain and worse cardiovascular health.
Circana reports GLP-1 users shift food purchases toward healthier options and higher health-benefit products.
Companies are adapting, and many former users may return to the medications.